EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Epidemiology of borderline ovarian tumors






Journal of the National Cancer Institute 78(1): 71-74

Epidemiology of borderline ovarian tumors

Ovarian tumors of low malignant potential, often termed "borderline tumors", have been defined as those that have some but not all of the morphologic features of malignancy (i.e., they are not invasive). With the use of data obtained by the western Washington population-based Cancer Surveillance System for 1975-83, the incidence of serous and mucinous borderline epithelial ovarian tumors was analyzed, as well as the survival of women who developed them. The incidence of borderline tumors increased with increasing age, although at a pace somewhat slower than that of malignant ovarian tumors. There was an upward trend in the incidence of borderline tumors starting in the late 1970's, a trend not present for malignant tumors. Only 12% of borderline tumors were not confined to the ovary, as opposed to 40% of malignant Grade I and 73% of other malignant ovarian neoplasms. At 5 years following diagnosis, the survival of women with borderline tumors was 93% that of the general female population. This percentage varied little by stage or histologic type. Given the reduced survival of women with these ovarian tumors and the lack of a sharp histological distinction between borderline and Grade I malignant lesions, it is recommended that borderline ovarian tumors be routinely ascertained by population-based cancer registries.


Accession: 005375921

PMID: 3025504

DOI: 10.1093/jnci/78.1.71



Related references

Kalapotharakos, G.; Högberg, T.; Bergfeldt, K.; Borgfeldt, C., 2016: Long-term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960-2007. We conducted an evaluation of incidence and survival of women with borderline ovarian tumors in Sweden. All women diagnosed with borderline ovarian tumor in the Swedish Cancer Register 1960-2007 (n = 6252) combined with follow up in the Swedish De...

Auranen, A.; Grénman, S.; Mäkinen, J.; Pukkala, E.; Sankila, R.; Salmi, T., 1996: Borderline ovarian tumors in Finland: epidemiology and familial occurrence. A total of 1,197 borderline ovarian tumors were reported to the Finnish Cancer Registry in 1973-1992. The mean age of the patients was 52 years, while the mean age of the 7,060 patients with an invasive epithelial ovarian carcinoma reported in the...

Harter, P.; Gershenson, D.; Lhomme, C.; Lecuru, F.; Ledermann, J.; Provencher, D.M.; Mezzanzanica, D.; Quinn, M.; Maenpaa, J.; Kim, J-Weon.; Mahner, S.; Hilpert, F.; Baumann, K.; Pfisterer, J.; du Bois, A., 2015: Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors). Since the early 1970s, the World Health Organization and the International Federation of Gynecology and Obstetrics have classified borderline ovarian tumors as an independent group of ovarian epithelial tumors. A consensus statement of the Gynecol...

Lawrence, W.Dwayne, 1995: The borderland between benign and malignant surface epithelial ovarian tumors: Current controversy over the nature and nomenclature of borderline ovarian tumors. In the early 1970s, the International Federation of Gynecology and Obstetrics (FIGO) and the World Health Organization (WHO) adopted the terms "borderline malignancy" and "carcinoma of low malignant potential" in their classifi...

Anonymous, 2007: Immunohistochemical study of the expression CD44 in serous, borderline, malign surface epithelial ovarian tumors and metastatic ovarian tumors

Lawrence, W.D., 1995: The borderland between benign and malignant surface epithelial ovarian tumors. Current controversy over the nature and nomenclature of "borderline" ovarian tumors. In the early 1970s, the International Federation of Gynecology and Obstetrics (FIGO) and the World Health Organization (WHO) adopted the terms "borderline malignancy" and "carcinoma of low malignant potential" in their classifi...

Kim, C.; Chung, H.Hoon.; Oh, S.Won.; Kang, K.Wook.; Chung, J-Key.; Lee, D.Soo., 2014: Differential Diagnosis of Borderline Ovarian Tumors from Stage I Malignant Ovarian Tumors using FDG PET/CT. Borderline ovarian tumors (BOTs) are more common in young women of reproductive age, and exhibit a better prognosis than malignant ovarian tumors (MOTs). Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) were compa...

Matsubayashi, R.Namoto.; Matsuo, Y.; Nakazono, T.; Momosaki, S.; Muranaka, T., 2015: Magnetic resonance imaging manifestations of ovarian mullerian mixed epithelial borderline tumors: imaging and histologic features in comparison with mullerian mucinous borderline tumors. We illustrate the magnetic resonance imaging features of 3 cases of rare ovarian Mullerian mixed epithelial borderline tumor (MEBT) and identify important diagnostic clues based on their detailed histologic, morphologic, and clinical features. Mul...

Luchian, A-Mihaela.; Pricop, M., 2011: Ovarian tumors of low malignant potential (borderline ovarian tumors). Ovarian borderline tumors are rare, their good prognosis depending on their stage at the time of diagnosis, and the presence of invasive implants. There is little information on tumor type identified intra-surgically, as well as on the most favora...

Anonymous, 2011: Ovarian stimulation for IVF treatment increases risk of borderline ovarian tumors later in life. New research from The Netherlands has shown that sub-fertile women whose ovaries are stimulated into producing extra eggs for in-vitro fertilization have an increased risk of ovarian malignancies, in particular borderline ovarian tumors, later in...